Remote Recurrent Primary Hyperparathyroidism in Auto-Transplanted Tissue.
auto-transplantation
hypercalcemia
medullary thyroid carcinoma
men2a
osteopenia
parathyroid hyperplasia
parathyroidectomy
pheochromocytoma
primary hyperparathyroidism
recurrent primary hyperparathyroidism
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
accepted:
20
06
2023
medline:
24
7
2023
pubmed:
24
7
2023
entrez:
24
7
2023
Statut:
epublish
Résumé
Multiple endocrine neoplasia type 2A (MEN2A) is a rare hereditary condition characterized by medullary thyroid cancer, pheochromocytoma, and primary hyperparathyroidism. The current standard of treatment of hyperparathyroidism involves surgical removal of visibly enlarged glands, and auto-transplantation of remnant tissue is often considered to minimize the risk of iatrogenic post-surgical hypocalcemia if multiple glands are enlarged. Rarely, hyperparathyroidism may recur due to hyperplasia or adenoma formation in the auto-transplanted tissue. The following case portrays a 51-year-old male, with a history of MEN2A status post total parathyroidectomy with cryopreservation and subsequent auto-transplantation of remnant parathyroid tissue to the left arm 18 years prior, who presented to establish care due to the insidious development of asymptomatic hypercalcemia. Workup included a laboratory examination showing elevated intact parathyroid hormone (PTH) and left arm ultrasound revealing three areas of enlarged parathyroid tissue at the transplant site, raising suspicion for the development of recurrent primary hyperparathyroidism in auto-transplanted tissue. The patient ultimately underwent a re-do subtotal parathyroidectomy of auto-transplanted tissue with surgical pathology confirming hyperplastic parathyroid tissue. This case highlights the significance of indefinite vigilant surveillance in this patient population, as a recurrence of hyperparathyroidism may occur even after decades of remission.
Identifiants
pubmed: 37485129
doi: 10.7759/cureus.40715
pmc: PMC10359832
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e40715Informations de copyright
Copyright © 2023, Esposito et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Nature. 1993 Jun 3;363(6428):458-60
pubmed: 8099202
Endocr Relat Cancer. 2018 Feb;25(2):T1-T13
pubmed: 29142004
Medicine (Baltimore). 1968 Sep;47(5):371-409
pubmed: 4386574
J Intern Med. 1995 Oct;238(4):369-73
pubmed: 7595174
Thyroid. 2015 Jun;25(6):567-610
pubmed: 25810047
Ann Surg Treat Res. 2016 Sep;91(3):145-8
pubmed: 27617256
JAMA Surg. 2016 Oct 1;151(10):959-968
pubmed: 27532368
J Am Coll Surg. 2000 May;190(5):546-52
pubmed: 10801021
Surgery. 1996 Dec;120(6):966-73; discussion 973-4
pubmed: 8957482
World J Surg. 2009 Nov;33(11):2234-43
pubmed: 19184636
Hum Mol Genet. 1993 Jul;2(7):851-6
pubmed: 8103403
Thyroid. 2009 Jun;19(6):565-612
pubmed: 19469690
Arch Surg. 2006 Dec;141(12):1199-205; discussion 1205
pubmed: 17178962
J Clin Endocrinol Metab. 2014 Oct;99(10):3595-606
pubmed: 25162669
World J Surg. 1996 Sep;20(7):808-12; discussion 812-3
pubmed: 8678955